Survey of the Health and Medical Research Sector to explore the impact of COVID-19 restrictions on research in Australia
30 April 2020 Research Australia is working to compile a comprehensive report for Australian governments to fully understand the impact COVID-19 is having on the sector. This brief survey is designed to gain insight into the impact of…
Read MoreEndGame MedTech – offering services for new technology success in the medical device market
30 April 2020 Are you commercialising a new technology for launch into the medical device market in the US? EndGame MedTech specialise in the unique challenges of commercializing new technology in the medical device market. Their team, including…
Read MoreNew genes linked to severe childhood speech disorder
30 April 2020 An international study led by Melbourne researchers has discovered nine new genes linked to the most severe type of childhood speech disorder, apraxia. The research analysed the genetic make-up of 34 affected children and young…
Read MoreHelping health professionals communicate in the era of COVID-19
27 April 2020 The University of Melbourne‘s “Communicating COVID-19″ course is designed for a wide range of healthcare providers both in hospital and community settings and will help provide expert-informed answers to questions Australian health care practitioners face surrounding…
Read MoreFree access to Clarivate’s BioWorld coronavirus articles
30 April 2020 Clarivate have provided free access to COVID-19 content in their BioWorld suite of news services. Viewers can access general news as well as three critical tables summarising: Vaccines and therapeutics in development Diagnostics on the…
Read MoreToyota supports Melbourne hospitals with locally designed face shields
26 April 2020 Toyota has utilised its advanced design, technology and production expertise to help assist the medical community in protecting them from the COVID-19 virus by developing and manufacturing desperately needed face shields. The face shields were…
Read MorePersonalised nutrition smart patch to be developed in Australia
27 April 2020 A wearable smart patch will deliver precision data to help people personalise their diets and reduce their risk of developing lifestyle-related chronic diseases like Type 2 diabetes. The world-first personalised nutrition wearable being developed by…
Read MoreOffspring may inherit legacy of their father’s Toxoplasma infection
29 April 2020 Melbourne researchers at the Walter and Eliza Hall Institute have revealed for the first time that males infected with the Toxoplasma parasite can impact their offspring’s brain health and behaviour. Studying mice infected with the common parasite Toxoplasma,…
Read MoreCracking the COVID-19 immunity code
29 April 2020 Monash University’s Dr James McMahon, an infectious disease expert and hospital clinician at The Alfred and Monash Health, is leading the development of a biobank aimed at cracking the immunity code of COVID-19. The biobank enables…
Read MoreUQ COVID-19 vaccine shown to induce potent protective response in pre-clinical trials
29 April 2020 The University of Queensland’s COVID-19 vaccine has passed another important milestone, showing the ability to raise high levels of antibodies that can neutralise the virus in early pre-clinical testing. UQ was tasked by the Coalition for Epidemic…
Read More83% Survival in COVID-19 ARDS Patients with Remestemcel-L
24 April 2020 Mesoblast Limited (ASX:MSB; Nasdaq: MESO) today announced 83% survival in ventilator-dependent COVID-19 patients (10/12) with moderate/severe acute respiratory distress syndrome (ARDS) treated during the period March-April 2020 with two intravenous infusions of Mesoblast’s allogeneic mesenchymal…
Read MoreImmutep Reports Positive Phase II TACTI-002 Data
28 April 2020 Immutep Limited (ASX: IMM; NASDAQ: IMMP), a biotechnology company developing novel immunotherapy treatments for cancer and autoimmune diseases, announces further positive interim data from its ongoing Phase II TACTI-002 study. The data relates to the…
Read More
